- Supply TypeManufacturer, Exporter, Supplier, Retailer
- Preferred Buyer Location All over the world
BEVACIZUMAB is a monoclonal antibody. It is used to treat cervical cancer, colorectal cancer, glioblastoma multiforme, non-small cell lung cancer (NSCLC), ovarian cancer, and renal cell cancer.